Multiple cranial neuropathy variant of Guillain-Barré syndrome: A case series

Muscle and Nerve

Volumn 44, Issue 2, 2011, Pages 252-257

  Wang, Qingsong ^a   Xiang, Yang ^a   Yu, Ke ^a   Li, Congyang ^a   Wang, Jun ^a   Xiao, Li ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Corticosteroid; Cranial nerve impairment; Diagnosis and treatment; GBS variant; Guillain barr ; Immunoglobulin; Syndrome

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; CRANIAL NEUROPATHY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DYSARTHRIA; DYSPHAGIA; ELECTROMYOGRAPHY; FACIAL NERVE DISEASE; FEMALE; GLOSSOPHARYNGEAL NERVE DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; LIMB WEAKNESS; LUMBAR PUNCTURE; MALE; MOTOR NERVE CONDUCTION; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSORY NERVE CONDUCTION; SLURRED SPEECH; TENDON REFLEX; TRACHEOSTOMY; TREATMENT DURATION; VAGUS NERVE DISEASE;

ADULT; AGED; CHILD; CRANIAL NERVE DISEASES; CRANIAL NERVES; ELECTRODIAGNOSIS; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION;

EID: 79960481141     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22043     Document Type: Article

References (24)

1. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366:1653-1666.
2. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008;7: 939-950.
3. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barré syndrome: an update. J Clin Neurosci 2009;16:733-741.
4. Kuwabara S. Guillain-Barre ́ syndrome: epidemiology, pathophysiology and management. Drugs 2004;64:597-610.
5. Korinthenberg R, Schessl J, Kirschner J. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study. Neuropediatrics 2007;38:10-17.
6. Govoni V, Granieri E, Tola MR, Casetta I, Ruppi P, Vaghi L. The frequency of clinical variants of Guillain-Barré syndrome in Ferrara, Italy. J Neurol 1999;246:1010-1014.
7. Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology 2008;70:1608-1613.
8. McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology 2009;32:150-163.
9. Narayanan RP, James N, Ramachandran K, Jaramillo MJ. Guillain-Barré syndrome presenting with bilateral facial nerve paralysis: a case report. Cases J 2008;1:379-381.
10. Polo A, Manganotti P, Zanette G, De Grandis D. Polyneuritis cranialis: clinical and electrophysiological findings. J Neurol Neurosurg Psychiatry 1992;55:398-400.
11. Keane JR. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 1994;44:1198-1202.
12. Lyu RK, Chen ST. Acute multiple cranial neuropathy: a variant of Guillain-Barré syndrome? Muscle Nerve 2004;30:433-436.
13. Asbury AK, Cornblath DR. Assessment of current diagnosis criteria for Guillain-Barre syndrome. Ann Neurol 1990;27(suppl):s21-24.
14. Kleyweg RP, van der Meche FGA, Schmitz PIM. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991;14:1103-1109.
15. Chiò A, Cocito D, Leone M, Giordana MT, Mora G, Mutani R, et al. Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey. Neurology 2003;60:1146-1150.
16. Brettschneider J, Petzold A, Süssmuth S, Tumani H. Cerebrospinal fluid biomarkers in Guillain-Barré syndrome-where do we stand? J Neurol 2009;256:3-12.
17. Edvardsson B, Persson S. Polyneuritis cranialis presenting with anti-GQ1b IgG antibody. J Neurol Sci 2009;281:125-126.
18. Kaida K, Sonoo M, Ogawa G, Kamakura K, Ueda-Sada M, Arita M, et al. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barré syndrome. Neurology 2008;71:1683-1690.
19. Kalita J, Misra UK, Das M. Neurophysiological criteria in the diagnosis of different clinical types of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2008;79:289-293.
20. Hui AC, Chow KM, Tang AS, Fu M, Kay R, Wong KS. Electrophysiological, clinical and epidemiological study of Guillain-Barré syndrome in Hong Kong Chinese. J Clin Neurosci 2005;12:134-136.
21. Hughes RA, Swan AV, van Koningsveld R, van Doorn PA. Corticosteroids for Guillain-Barre ́ syndrome. Cochrane Database Syst Rev 2006;2:CD001446.
22. Hughes RA, Swan AV, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev 2010;2: CD001446.
23. Hughes RA, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 2007;130:2245-2257.
24. Elovaara I, Apostolski S, van Doorn P, Gilhus NE, Hietaharju A, Honkaniemi J, et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol 2008;15:893-908.